The Effect of Ursodeoxycholic Acid on Small Intestinal Bacterial Overgrowth in Patients with Functional Dyspepsia: A Pilot Randomized Controlled Trial

被引:15
作者
Kim, Bom-Taeck [1 ]
Kim, Kwang-Min [1 ]
Kim, Kyu-Nam [1 ]
机构
[1] Ajou Univ, Dept Family Practice & Community Hlth, Sch Med, Suwon 16499, South Korea
关键词
functional dyspepsia; small intestinal bacterial overgrowth; ursodeoxycholic acid; GASTROINTESTINAL DISORDERS; METHANE; PATHOPHYSIOLOGY; DISRUPTION; RIFAXIMIN; THERAPY; TRANSIT; SOLIDS;
D O I
10.3390/nu12051410
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Functional dyspepsia (FD) is associated with small intestinal bacterial overgrowth (SIBO). Several animal studies have reported that ursodeoxycholic acid (UDCA) has antibacterial and anti-inflammatory effects in the intestine. We hypothesized that UDCA may be effective against dyspeptic symptoms and SIBO in patients with FD. We conducted this randomized controlled trial to investigate the effects of UDCA in FD patients with SIBO. Twenty-four patients diagnosed with FD and SIBO based on lactulose breath test (LBT) were randomly assigned to either a UDCA treatment group or an untreated group. The treatment group received 100 mg of UDCA three times per day for two months; the untreated group was monitored for two months without intervention. After two months in both groups, we reevaluated LBT and FD symptoms using the Nepean dyspepsia index-K. FD symptoms in the UDCA-treated group were significantly reduced after two months compared with baseline and FD symptom scores between the UDCA-treated and untreated groups showed statistically significant differences after two months. In addition, the total methane gas levels for 90 minutes in LBT were significantly decreased after two months compared with baseline in the UDCA-treated group. In this preliminary exploratory study, we found that two months of UDCA treatment resulted in FD symptom improvement and reduced methane values during 90 minutes on the LBT, suggesting that methane-producing SIBO were associated with symptoms of dyspepsia and that UDCA was helpful in these patients. These findings need to be validated via large-scale controlled and well-designed studies.
引用
收藏
页数:11
相关论文
共 29 条
[1]   Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress [J].
Cao, Aili ;
Wang, Li ;
Chen, Xia ;
Guo, Hengjiang ;
Chu, Shuang ;
Zhang, Xuemei ;
Peng, Wen .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (08) :1300-1308
[2]   Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis [J].
Chung, Jihwa ;
An, Shung Hyun ;
Kang, Sang Won ;
Kwon, Kihwan .
PLOS ONE, 2016, 11 (01) :1-18
[3]   Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV [J].
Drossman, Douglas A. .
GASTROENTEROLOGY, 2016, 150 (06) :1262-+
[4]   Micro-inflammation in functional dyspepsia: A systematic review and meta-analysis [J].
Du, L. ;
Chen, B. ;
Kim, J. J. ;
Chen, X. ;
Dai, N. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (04)
[5]   Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis [J].
Du, Li-Jun ;
Chen, Bin-Rui ;
Kim, John J. ;
Kim, Sarah ;
Shen, Jin-Hua ;
Dai, Ning .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (12) :3486-3495
[6]   Slow Transit Constipation Associated With Excess Methane Production and Its Improvement Following Rifaximin Therapy: A Case Report [J].
Ghoshal, Uday C. ;
Srivastava, Deepakshi ;
Verma, Abhai ;
Misra, Asha .
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2011, 17 (02) :185-188
[7]  
Costa Michelle Bafutto Gomes, 2012, Arq. Gastroenterol., V49, P279, DOI 10.1590/S0004-28032012000400009
[8]   Ways of measuring drinking patterns and the difference they make: experience with graduated frequencies [J].
Greenfield, TK .
JOURNAL OF SUBSTANCE ABUSE, 2000, 12 (1-2) :33-49
[9]   Beneficial effects of ursodeoxycholic acid via inhibition of airway remodelling, apoptosis of airway epithelial cells, and Th2 immune response in murine model of chronic asthma [J].
Isik, S. ;
Karaman, M. ;
Micili, S. Cilaker ;
Caglayan-Sozmen, S. ;
Bagriyanik, H. Alper ;
Arikan-Ayyildiz, Z. ;
Uzuner, N. ;
Karaman, O. .
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2017, 45 (04) :339-349
[10]  
Lee S. Y, 2003, KOR J NEUROGASTROE S, V15, P48